Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain

NCT ID: NCT01390103

Last Updated: 2013-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to determine the effect of hip injections on hip biomechanics in patients with hip pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Assessment following the hip injection

Assessment to evaluate the effect of the hip injection on biomechanics.

Assessment following hip injection

Intervention Type OTHER

Assessment to evaluate the effect of the hip injection on biomechanics.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment following hip injection

Assessment to evaluate the effect of the hip injection on biomechanics.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Osteoarthritis patients with hip pain requiring hip injection
* Receiving hip injection
* BMI \< 35

Exclusion Criteria

* BMI \> 35
* severely impaired intellectual capacity
* dementia, or other neurodegenerative diseases that would preclude appropriate cognitive or physical ability to perform study protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MaryBeth Horodyski, PhD

Role: STUDY_DIRECTOR

University of Florida Departmen of Orthopaedics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UF&Shands Orthopaedics and Sports Medicine Institute

Gainesville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

711-2010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Total Hip Registry
NCT01133249 UNKNOWN
Hip Impingement - Understanding Cartilage Damage
NCT01546493 ACTIVE_NOT_RECRUITING NA